Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2012 2
2013 1
2014 2
2015 2
2016 1
2017 2
2019 3
2020 5
2021 4
2022 8
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Unresectable Liver and Intrahepatic Bile Duct Carcinoma"
Page 1
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline.
Apisarnthanarax S, Barry A, Cao M, Czito B, DeMatteo R, Drinane M, Hallemeier CL, Koay EJ, Lasley F, Meyer J, Owen D, Pursley J, Schaub SK, Smith G, Venepalli NK, Zibari G, Cardenes H. Apisarnthanarax S, et al. Pract Radiat Oncol. 2022 Jan-Feb;12(1):28-51. doi: 10.1016/j.prro.2021.09.004. Epub 2021 Oct 21. Pract Radiat Oncol. 2022. PMID: 34688956
PURPOSE: This guideline provides evidence-based recommendations for the indications and technique-dose of external beam radiation therapy (EBRT) in hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC). METHODS: The American Society for Rad …
PURPOSE: This guideline provides evidence-based recommendations for the indications and technique-dose of external beam radiation therapy (E …
Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis.
Mosconi C, Solaini L, Vara G, Brandi N, Cappelli A, Modestino F, Cucchetti A, Golfieri R. Mosconi C, et al. Cardiovasc Intervent Radiol. 2021 May;44(5):728-738. doi: 10.1007/s00270-021-02800-w. Epub 2021 Mar 11. Cardiovasc Intervent Radiol. 2021. PMID: 33709272
PURPOSE: Intrahepatic cholangiocarcinoma (ICC) has a poor prognosis, when unresectable; therefore, intra-arterial therapies (IAT) such as trans-arterial chemoembolization (TACE) and trans-arterial radioembolization (TARE) have been employed. ...Therefore, the …
PURPOSE: Intrahepatic cholangiocarcinoma (ICC) has a poor prognosis, when unresectable; therefore, intra-arterial thera …
Current therapy of hilar cholangiocarcinoma.
Lau SH, Lau WY. Lau SH, et al. Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):12-7. doi: 10.1016/s1499-3872(11)60119-7. Hepatobiliary Pancreat Dis Int. 2012. PMID: 22251465 Review.
For the curative treatment, local excision should only be used on small tumors which are confined to the bile duct wall and Bismuth I papillary carcinoma. Partial hepatectomy should be combined with caudate lobe resection and porta-hepatis lymph node dissecti …
For the curative treatment, local excision should only be used on small tumors which are confined to the bile duct wall and Bi …
Transarterial Yttrium-90 Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Schartz DA, Porter M, Schartz E, Kallas J, Gupta A, Butani D, Cantos A. Schartz DA, et al. J Vasc Interv Radiol. 2022 Jun;33(6):679-686. doi: 10.1016/j.jvir.2022.02.016. Epub 2022 Feb 25. J Vasc Interv Radiol. 2022. PMID: 35219834 Review.
PURPOSE: To investigate the overall efficacy and survival profile of yttrium-90 ((90)Y) radioembolization for unresectable intrahepatic cholangiocarcinoma (ICC). MATERIALS AND METHODS: A systematic literature review and meta-analysis was completed using a ran …
PURPOSE: To investigate the overall efficacy and survival profile of yttrium-90 ((90)Y) radioembolization for unresectable intrahe …
Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Holster JJ, El Hassnaoui M, Franssen S, IJzermans JNM, de Jonge J, Mostert B, Polak WG, de Wilde RF, Homs MYV, Groot Koerkamp B. Holster JJ, et al. Ann Surg Oncol. 2022 Sep;29(9):5528-5538. doi: 10.1245/s10434-022-11439-x. Epub 2022 Mar 16. Ann Surg Oncol. 2022. PMID: 35294656 Free PMC article. Review.
BACKGROUND: Patients with unresectable intrahepatic cholangiocarcinoma (iCCA) have poor survival. This systematic review describes the survival outcomes of hepatic arterial infusion pump (HAIP) chemotherapy with floxuridine for patients with unresectable …
BACKGROUND: Patients with unresectable intrahepatic cholangiocarcinoma (iCCA) have poor survival. This systematic revie …
Survival outcomes of hepatic resections in Bismuth-Corlette type IV cholangiocarcinoma.
Ku D, Tang R, Pang T, Pleass H, Richardson A, Yuen L, Lam V. Ku D, et al. ANZ J Surg. 2020 Sep;90(9):1604-1614. doi: 10.1111/ans.15531. Epub 2019 Dec 15. ANZ J Surg. 2020. PMID: 31840387 Review.
Two reviewers independently screened and selected papers that contained survival data on BC-IV cholangiocarcinoma after hepatic resections. RESULTS: Of 13 499 papers from our search result, 21 papers satisfied the inclusion criteria. ...CONCLUSION: Our analysis demonstrate …
Two reviewers independently screened and selected papers that contained survival data on BC-IV cholangiocarcinoma after hepatic resec …
Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysis.
Han K, Ko HK, Kim KW, Won HJ, Shin YM, Kim PN. Han K, et al. J Vasc Interv Radiol. 2015 Jul;26(7):943-8. doi: 10.1016/j.jvir.2015.02.024. Epub 2015 Apr 18. J Vasc Interv Radiol. 2015. PMID: 25899049 Review.
The purpose of this study was to perform a meta-analysis and systematic review of the clinical efficacy and safety of radiofrequency (RF) ablation in the treatment of intrahepatic cholangiocarcinoma (ICC). A comprehensive literature search of Ovid MEDLINE and EMBASE …
The purpose of this study was to perform a meta-analysis and systematic review of the clinical efficacy and safety of radiofrequency (RF) ab …
Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.
Al-Adra DP, Gill RS, Axford SJ, Shi X, Kneteman N, Liau SS. Al-Adra DP, et al. Eur J Surg Oncol. 2015 Jan;41(1):120-7. doi: 10.1016/j.ejso.2014.09.007. Epub 2014 Oct 7. Eur J Surg Oncol. 2015. PMID: 25449754 Free PMC article. Review.
Radioembolization with yttrium-90 microspheres offers an alternative treatment option for patients with unresectable intrahepatic cholangiocarcinoma (ICC). However, the rarity and heterogeneity of ICC makes it difficult to draw firm conclusions about treatmen …
Radioembolization with yttrium-90 microspheres offers an alternative treatment option for patients with unresectable intrahepatic …
Outcomes of ex vivo liver resection and autotransplantation: A systematic review and meta-analysis.
Zawistowski M, Nowaczyk J, Jakubczyk M, Domagała P. Zawistowski M, et al. Surgery. 2020 Oct;168(4):631-642. doi: 10.1016/j.surg.2020.05.036. Epub 2020 Jul 26. Surgery. 2020. PMID: 32727659 Free article.
BACKGROUND: Many patients with hepatic tumors cannot benefit from resection owing to the difficult anatomic sites of their lesions. Some of these patients might be eligible for ex vivo liver resection and autotransplantation. This procedure consists of complete hepatectomy …
BACKGROUND: Many patients with hepatic tumors cannot benefit from resection owing to the difficult anatomic sites of their lesions. Some of …
Locoregional therapy combined with systemic therapy (LRT + ST) for unresectable and metastatic intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Zhang M, Qi W, Qiu X, Yu C, Qiu W, Wang S, Qiu Z. Zhang M, et al. Radiol Oncol. 2023 Nov 30;57(4):419-429. doi: 10.2478/raon-2023-0059. eCollection 2023 Dec 1. Radiol Oncol. 2023. PMID: 38038416 Free PMC article. Review.
BACKGROUND: The outcome of systemic therapy (ST) for unresectable and metastatic intrahepatic cholangiocarcinoma (iCCA) is poor. ...CONCLUSIONS: Compared with only ST, LRT + ST improved survival outcomes for unresectable and metastatic iCCA patients wi …
BACKGROUND: The outcome of systemic therapy (ST) for unresectable and metastatic intrahepatic cholangiocarcinoma (iCCA) …
27 results